Recce secures major Brazilian anti-infective patent
Recce Pharmaceuticals (ASX:RCE) has been granted a Family 4 patent for its proprietary synthetic anti-infectives.
Recce Pharmaceuticals (ASX:RCE) has been granted a Family 4 patent for its proprietary synthetic anti-infectives.
Latitude Group (ASX:LFS) launched an offer for Capital Notes 2, aiming to raise approximately $100 million to strengthen its capital structure.
Group 6 Metals (ASX:G6M) has formalised a multi-year extension to its offtake agreement with the global commodities powerhouse Traxys Europe.
Australia and the EU sign a historic free trade deal, eliminating 99% of tariffs and sparking a $10 billion economic windfall.
Alisa Mall, chief investment officer for Michael Dell's family office, says tumult in private-credit markets is turning into a buying opportunity.
Echo IQ (ASX: EIQ) announced an expanded agreement to distribute its AI-driven heart failure solution, EchoSolv HF.
Clover Corporation (ASX:CLV) has delivered a robust financial performance for the first half of 2026.
APRA has issued a stark warning regarding the nation's financial stability, revealing that climate-driven spikes in insurance premiums are poised to trigger a "protection gap."
BofA's Winnie Wu says investors are starting to price in prolonged inflationary pressure. She tells Bloomberg Television that the current environment highlights the importance of diversifying positions.
Strata Minerals (ASX:SMX) has mobilised for its Phase 2 drilling program at the 100%-owned Zelica Gold Project.
Tech titan Oracle has launched its AI Customer Excellence Centre in Sydney.
Sparc Technologies (ASX:SPN) signs LOI with HydroGraph Clean Power to integrate "Fractal Graphene" into ecosparc protective coatings.